[Trials in pressure regulation with metipranolol eyedrops in special forms of glaucoma in ophthalmologic practice].
This paper presents the results of a study on the effect of Metipranolol eye drops (Betamann) in 10 patients. The drops were tested with the following forms of glaucoma: glaucoma associated with alpha-kia, neovascular glaucoma, exfoliative glaucoma, pigmentary glaucoma, juvenile glaucoma. Some patients required treatment in combination with miotics. Metipranolol eye drops reduced intraocular pressure by about 15 percent for a prolonged period of time. The pressure-lowering effect was maintained during an observation period of twelve months. Visual acuity and visual fields were constant. The drug was tolerated well subjectively by almost all the patients.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002387:Cataract Extraction; D005260:Female; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects*; D008297:Male; D014290:Metipranolol / Q000627:therapeutic use*; D008875:Middle Aged; D009883:Ophthalmic Solutions; D011183:Postoperative Complications / Q000188:drug therapy; D011412:Propanolamines / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D011412:Propanolamines; D014290:Metipranolol
Versuche der Druckeinstellung mit Metipranolol-Augentropfen bei einigen Glaukomsonderformen in der augenärztlichen Praxis.